Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanyan Fang

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Epilepsia|October 19, 2022
Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence studyLanyan Fang, Zhichuan Li, Minori Kinjo, et al.
Pharmaceutical Research|June 3, 2025
Adopting the Model Master File Framework to Enhance Modeling and Simulations Approaches for Regulatory UseLanyan Fang, Eleftheria Tsakalozou, Fang Wu, et al.
The AAPS Journal|January 2, 2016
Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology PerspectiveYow-Ming C Wang, Jie Wang, Yuen Yi Hon, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 22, 2023
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipineMing-Liang Tan, Zongming Gao, Andrew Babiskin, et al.
Clinical Pharmacology and Therapeutics|January 18, 2019
Evaluating Within-Subject Variability for Narrow Therapeutic Index DrugsPriya Jayachandran, Hideaki Okochi, Lynda A Frassetto, et al.
The AAPS Journal|April 8, 2024
Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public WorkshopArindom Pal, Fang Wu, Ross Walenga, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2025
Impact of Mechanistic Modeling and Simulation Methodologies on Product-Specific Guidance Development for Non-Orally Administered Drug ProductsSteven G Chopski, Ross L Walenga, Ming-Liang Tan, et al.
Clinical and Translational Science|October 5, 2025
Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival ForestRobert Hopefl, Jing Wang, Abhinav Ram Mohan, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsHenrik Bjugård Nyberg, Xiaomei Chen, Mark Donnelly, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Epilepsia|October 19, 2022
Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence studyLanyan Fang, Zhichuan Li, Minori Kinjo, et al.
Pharmaceutical Research|June 3, 2025
Adopting the Model Master File Framework to Enhance Modeling and Simulations Approaches for Regulatory UseLanyan Fang, Eleftheria Tsakalozou, Fang Wu, et al.
The AAPS Journal|January 2, 2016
Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology PerspectiveYow-Ming C Wang, Jie Wang, Yuen Yi Hon, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 22, 2023
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipineMing-Liang Tan, Zongming Gao, Andrew Babiskin, et al.
Clinical Pharmacology and Therapeutics|January 18, 2019
Evaluating Within-Subject Variability for Narrow Therapeutic Index DrugsPriya Jayachandran, Hideaki Okochi, Lynda A Frassetto, et al.
The AAPS Journal|April 8, 2024
Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public WorkshopArindom Pal, Fang Wu, Ross Walenga, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2025
Impact of Mechanistic Modeling and Simulation Methodologies on Product-Specific Guidance Development for Non-Orally Administered Drug ProductsSteven G Chopski, Ross L Walenga, Ming-Liang Tan, et al.
Clinical and Translational Science|October 5, 2025
Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival ForestRobert Hopefl, Jing Wang, Abhinav Ram Mohan, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2024
Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsHenrik Bjugård Nyberg, Xiaomei Chen, Mark Donnelly, et al.
Pageof 7